- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
In 1918, a strain of influenza, popularly known as the Spanish flu, ravaged the globe, killing an estimated 2.5% of the world's population. Now, concerns about new pandemics have led the global public health community to seek early warning systems to identify disease "hot spots" and enable rapid responses to prevent epidemics. The technological breakthrough that epidemiologists are looking for exists with QualSec's NanoNose.
As environmental changes worldwide bring people in greater contact with animals, zoonoses - diseases that can transfer between humans and animals - are increasingly emerging as threats, including diseases like avian influenza, hantavirus, Ebola and West Nile viruses. QualSec's NanoNose uses patented breakthroughs in nanotechnology for rapid data collection, allowing health officials better disease surveillance and vulnerability mapping.
This electronic nose technology developed by QualSec will be able to rapidly identify "hot spots" that could become epidemic nodes. Rapid detection is crucial for effective epidemic intelligence.
QualSec's NanoNose is highly portable and rugged, and can be easily deployed to remote areas and used by operators with minimal training to detect epidemics before they spread. Though the sensor is designed to process data individually, it can be linked into a wireless network and transmit findings of disease to a central response center, where global health organizations can react to disease outbreaks.
QualSec believes that this press release contains forward-looking statements as that term is defined by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties. Such statements are based on management's current expectations and are subject to facts that could cause results to differ materially from the forward-looking statements. For further information you are encouraged to view QualSec's filings with the Securities and Exchange Commission, including its annual report on Form 10K for the period ending December 31, 2007. The Company assumes no obligation to update the information contained in this press release.
For more information, please click here
QualSec Investor Relations
David Stern, 919-928-4510
QualSec Press Relations
Ann Johnston, 919-237-3833
Additional materials available upon request.
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
New nanomedicine approach aims to improve HIV drug therapies October 24th, 2016
Nanosciences: Genes on the rack October 21st, 2016
Nanoparticle vaccinates mice against dengue fever October 21st, 2016